162 related articles for article (PubMed ID: 35007294)
1. Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo.
Fuchs AA; Balne PK; Giuliano EA; Sinha NR; Mohan RR
PLoS One; 2022; 17(1):e0262046. PubMed ID: 35007294
[TBL] [Abstract][Full Text] [Related]
2. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
[TBL] [Abstract][Full Text] [Related]
3. Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo.
Gupta S; Fink MK; Ghosh A; Tripathi R; Sinha PR; Sharma A; Hesemann NP; Chaurasia SS; Giuliano EA; Mohan RR
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1045-1057. PubMed ID: 29490341
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK.
Møller-Pedersen T; Cavanagh HD; Petroll WM; Jester JV
Curr Eye Res; 1998 Jul; 17(7):736-47. PubMed ID: 9678420
[TBL] [Abstract][Full Text] [Related]
6. Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.
Gupta S; Fink MK; Kempuraj D; Sinha NR; Martin LM; Keele LM; Sinha PR; Giuliano EA; Hesemann NP; Raikwar SP; Chaurasia SS; Mohan RR
Mol Ther; 2022 Oct; 30(10):3257-3269. PubMed ID: 35780298
[TBL] [Abstract][Full Text] [Related]
7. Latrunculin B and substratum stiffness regulate corneal fibroblast to myofibroblast transformation.
Thomasy SM; Raghunathan VK; Miyagi H; Evashenk AT; Sermeno JC; Tripp GK; Morgan JT; Murphy CJ
Exp Eye Res; 2018 May; 170():101-107. PubMed ID: 29421383
[TBL] [Abstract][Full Text] [Related]
8. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
9. BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo.
Tandon A; Sharma A; Rodier JT; Klibanov AM; Rieger FG; Mohan RR
PLoS One; 2013; 8(6):e66434. PubMed ID: 23799103
[TBL] [Abstract][Full Text] [Related]
10. Descemet's membrane injury and regeneration, and posterior corneal fibrosis, in rabbits.
Sampaio LP; Shiju TM; Hilgert GSL; de Oliveira RC; DeDreu J; Menko AS; Santhiago MR; Wilson SE
Exp Eye Res; 2021 Dec; 213():108803. PubMed ID: 34736886
[TBL] [Abstract][Full Text] [Related]
11. A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study.
Tripathi R; Balne PK; Sinha NR; Martin LM; Kamil S; Landreneau JR; Gupta S; Rodier JT; Sinha PR; Hesemann NP; Hofmann AC; Fink MK; Chaurasia SS; Mohan RR
Transl Vis Sci Technol; 2020 Nov; 9(12):6. PubMed ID: 33200047
[TBL] [Abstract][Full Text] [Related]
12. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts.
Mohan RR; Gupta R; Mehan MK; Cowden JW; Sinha S
Exp Eye Res; 2010 Aug; 91(2):238-45. PubMed ID: 20546727
[TBL] [Abstract][Full Text] [Related]
13. The corneal fibrosis response to epithelial-stromal injury.
Torricelli AA; Santhanam A; Wu J; Singh V; Wilson SE
Exp Eye Res; 2016 Jan; 142():110-8. PubMed ID: 26675407
[TBL] [Abstract][Full Text] [Related]
14. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of corneal fibrosis by Smad7 in rats after photorefractive keratectomy.
Wang T; Zhou XT; Yu Y; Zhu JY; Dai JH; Qu XM; Le QH; Chu RY
Chin Med J (Engl); 2013; 126(8):1445-50. PubMed ID: 23595375
[TBL] [Abstract][Full Text] [Related]
16. Trichostatin a inhibits corneal haze in vitro and in vivo.
Sharma A; Mehan MM; Sinha S; Cowden JW; Mohan RR
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2695-701. PubMed ID: 19168895
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel in vivo corneal fibrosis model in the dog.
Gronkiewicz KM; Giuliano EA; Kuroki K; Bunyak F; Sharma A; Teixeira LB; Hamm CW; Mohan RR
Exp Eye Res; 2016 Feb; 143():75-88. PubMed ID: 26450656
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine decreases formation of myofibroblasts and excessive extracellular matrix production in an in vitro human corneal fibrosis model.
Słoniecka M; Danielson P
J Cell Mol Med; 2020 Apr; 24(8):4850-4862. PubMed ID: 32176460
[TBL] [Abstract][Full Text] [Related]
19. Epithelial basement membrane injury and regeneration modulates corneal fibrosis after pseudomonas corneal ulcers in rabbits.
Marino GK; Santhiago MR; Santhanam A; Lassance L; Thangavadivel S; Medeiros CS; Bose K; Tam KP; Wilson SE
Exp Eye Res; 2017 Aug; 161():101-105. PubMed ID: 28506643
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
Freise C; Querfeld U
Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
